* Japanese*
The University of Tokyo , Faculty of Pharmaceutical Science
1989.03 , Graduated
The University of Tokyo , Graduate School, Division of Pharmaceutical Sciences
Doctor Course , 1994.03 , Completed
Duty , Asahikawa Medical University Hospital Pharmacy Department , Professor , 2013.05 -
Concurrently , Asahikawa Medical University Hospital , Deputy Hospital Director , 2018.07 - 2019.06
Duty , Asahikawa Medical University Hospital Pharmacy Department , Associate Professor , 2004.08 - 2013.05
Yamanouchi Pharmaceutical Co., Ltd. , Chief Researcher , 2000.08 - 2004.07
Yamanouchi Pharmaceutical Co., Ltd. , Researcher , 1994.04 - 2000.07
General pharmacology
Medical pharmacy
College of Pharamacy & University Medical Center, Unviersity of Arizona (UNITED STATES) , Visiting Scholar , 2008.11 - 2009.03
English: Takashi Bando, Masayuki Chuma, Hirofumi Hamano, Takahiro Niimura , Naoto Okada, Masateru Kondo, Yuki Izumi, Shunsuke Ishida, Toshihiko Yoshioka, Mizuho Asada , Yoshito Zamami, Kenshi Takechi , Mitsuhiro Goda, Koji Miyat, Kenta Yagi , Yuki Izawa-Ishizawa, Momoyo Azuma , Hiroaki Yanagawa, Yoshikazu Tasaki, and Keisuke Ishizawa, Concomitant Use of Multiple Nephrotoxins including Renal Hypoperfusion Medications Causes Vancomycin-Associated Nephrotoxicity―Combined Retrospective Analyses of Two Real-World Databases. , Acta Medica Okayama , vol.77 (6) (p.595 - 605) , 2023
English: Manabe T, Iwayama K, Chuma M, Tasaki Y and Matsumoto S, The effect of concomitant usage of analgesics on immune checkpoint inhibitor-related interstitial lung disease. , In Vivo , vol.37 (3) (p.1260 - 1265) , 2023 , (IF:2.406)
English: Chuma M, Hamano H, Bando T, Kondo M, Okada N, Izumi Y, Ishida S, Yoshioka T, Asada M, Niimura T, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Kasamo S, Izawa-Ishizawa Y, Azuma M, Yanagawa H, Tasaki Y, Keisuke Ishizawa K., Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes—combined retrospective analyses of two real-world databases. , Basic Clin Pharmacol Toxicol, , vol.131 (6) (p.525 - 535) , 2022 , (IF:3.688)
English: Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Ishizawa K, Tasaki Y., Association between statin use and daptomycin-related musculoskeletal adverse events. , International Symposium, The 32nd Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences, 2022. , 2022
English: Chiba T, Ujiie H, Yaegashi Y, Umehara K, Takada S, Otaki K, Sako KI, Nakamaru Y, Meada T, Kudo K, Tasaki Y, Sato H., Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab , Biomedical Reports , vol.17 (3) , 2022 , (IF:1.944)
The Multiple Authorship :A novel endogenous amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ) in Parkinsonian CSF, and its toxicological effect , Plenum Press , 1993 , Y. Tasaki, Y. Kotake, Y. Makino, S. Ohta and M. Hirobe
The Book (the science book)
The Multiple Authorship :Importance of 1-methyltetrahaydroisoquinoline (1MeTIQ) in Parkinson’s disease , Plenum Press , 1990 , S.Ohta, Y. Tasaki, Y. Makino, O. Tachikawa, and M. Hirobe.
The Book (the science book)
The Multiple Authorship :Formation of a novel and neurotoxic tetrahydroisoquinoline derivative, 1,3- dimethyltetrahydroisoquinoline (1,3DiMe TIQ), a condensation product of amphetamine in vivo , Plenum Press , 1990 , Y. Makino, Y. Tasaki, M.Kashiwasake, O. Tachikawa, and M. Hirobe.
The Book (the science book)
English: Y. Tasaki, Y. Makino, S. Ohta and M. Hirobe., Biosynthesis of 1-methyl-1,2,3,4- tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent. , Raven Press , Parkinson's Disease: from basic research to treatment , 1992
English: S. Ohta, M. Kohno, Y. Makino, O. Tachikawa, Y. Tasaki, K. Kikuchi and M. Hirobe., Relationship between TIQs and Parkinson’s Disease. , Springer Verlag , Parkinson's Disease: From Clinical Aspects to Molecular Basis , 1991
The International Conference: 19th World Congress of Basic & Clinical Pharmacology (WCP2023) , 2023.07
The International Conference: Forbidden City International Pharmacist Conference , 2023.07
The International Conference: The 29th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences , 2019.11
Partner division:Private Enterprise , 2020.04 - 2022.03
2020year , Partaker , 247,500yen
Partner division:Others , 2014.11 -
Updated on 2024/04/08
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.
